Last updated: August 17, 2026

Stem Cell Therapy for Liver Fibrosis: An Overview

Liver fibrosis is a chronic liver disease characterized by the excessive deposition of extracellular matrix proteins, leading to the formation of scar tissue and impaired liver function. Stem cell therapy has emerged as a promising approach for treating liver fibrosis, offering the potential to regenerate damaged liver tissue and restore liver function.

Pathophysiology of Liver Fibrosis and Stem Cell Potential

Liver fibrosis is triggered by chronic liver injury, which activates hepatic stellate cells (HSCs). HSCs differentiate into myofibroblasts, the main producers of extracellular matrix proteins. Stem cells, due to their self-renewal and differentiation capabilities, have the potential to modulate the fibrotic process by inhibiting HSC activation, promoting hepatocyte regeneration, and reducing inflammation.

Types of Stem Cells Used in Liver Fibrosis Treatment

Various types of stem cells have been investigated for liver fibrosis therapy, including:

  • Mesenchymal stem cells (MSCs): Derived from bone marrow, adipose tissue, or umbilical cord, MSCs can differentiate into multiple cell types, including hepatocytes and cholangiocytes.
  • Hepatic stem cells (HSCs): Found in the liver, HSCs are responsible for liver regeneration and can be expanded in vitro for therapeutic use.
  • Embryonic stem cells (ESCs): Derived from blastocysts, ESCs have the potential to differentiate into any type of cell, offering a versatile source for liver fibrosis therapy.
Scientific case review

Scientific Case Review

Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?

Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.

  • Review of the information you provide
  • Relevant research and clinical program information
  • A clear response focused on your situation
What happens next? Send your question, receive a focused scientific review, and get a clear response about research and clinical programs relevant to your situation.
Your scientific review will be prepared by Dr. Helen Melnik, PhD , who has more than 25 years of experience in stem cell research and international clinical programs.

No obligation. Your question will be reviewed confidentially.

Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.

WhatsApp